Skip to main content

Table 4 Laboratory and Clinical Outcomes of CBAVD Couples with and without CFTR Mutation in ICSI Cycles

From: Genetic diagnosis and outcomes of intracytoplasmic sperm injection in South Chinese patients with congenital bilateral aplasia of the vas deferens

Characteristic

CFTR Mutation

no- CFTR Mutation

P

n

30

11

 

Male age (years)

32(30 ~ 33)

31(27 ~ 33)

0.145

Female age (years)

29(27.2 ~ 33)

30(28 ~ 34)

0.171

Fertilization rate

77.1% (293/380)

72.4% (92/127)

0.28

2PN rate

79.5% (233/293)

77.2% (71/92)

0.66

Average number of available embryos

5(3 ~ 6.75)

3(1.5 ~ 6.5)

0.18

Clinical pregnancy rate/fresh ET (n)

60% (18/30)

63.6% (7/11)

1

Miscarriage Rate

16.7% (3/18)

14.2% (1/7)

1

Live Birth Rate

50% (15/30)

54.5% (52/112)

1

  1. This table compares the laboratory and clinical outcomes of couples with CBAVD undergoing ICSI cycles, divided into groups based on the presence or absence of CFTR mutations
  2. Categorical variables were presented as % (n/N) and compared using the Fisher's precision probability test
  3. Continuous variables were presented as medians (first quartile-third quartile) and compared using the Mann–Whitney U rank-sum test
  4. CFTR Cystic fibrosis transmembrane conductance regulator, 2PN rate 2 Pronuclei rate
  5. P value < 0.05 was considered statistically significant